Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Tuesday 30 March, 2021

Benchmark Hlgs PLC

Listing of existing senior secured NOK bond

RNS Number : 8812T
Benchmark Holdings PLC
30 March 2021

30 March 2021


Benchmark Holdings plc

("Benchmark" or the "Company")


Listing of existing senior secured NOK bond ISIN NO 0010858210


Benchmark, the aquaculture biotechnology company, notifies that further to the announcement made on 13 June 2019, the Company has today listed its existing NOK 850 million senior secured floating rate bond (the "bond") on the Oslo Stock Exchange. The listing of the bond satisfies the last remaining condition under the terms of the bond. As previously announced, the bond has a coupon of three months NIBOR* + 5.25% p.a. with quarterly interest payments and matures in June 2023.


A copy of the prospectus which was approved by the NFSA, the Norwegian Financials Supervisory Authority, on 11th March 2021 is available at


*The three month NIBOR (Norwegian Interbank Offered Rate) stood at 0.38% as at 29 March 2021.




Benchmark Holdings plc

Tel:  +44(0) 20 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel:  +44(0) 20 7260 1000

James Black, Freddie Barnfield, Duncan Monteith  

MHP Communications

Tel:  +44(0) 20 3128 8742

Katie Hunt, Reg Hoare, Alistair de Kare-Silver   

[email protected]



About Benchmark 

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability. We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t